US 11529360
Natural combination hormone replacement formulations and therapies
granted A61KA61K31/565A61K31/57
Quick answer
US patent 11529360 (Natural combination hormone replacement formulations and therapies) held by Compass Therapeutics LLC expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Compass Therapeutics LLC
- Grant date
- Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/565, A61K31/57, A61K47/10, A61K47/14